Doodipala S. Reddy

Mass spectrometric assay and physiological-pharmacological activity of androgenic neurosteroids

[Review of ]. Neurochemistry International, 52(4-5), 541–553.

Differential anesthetic activity of ketamine and the GABAergic neurosteroid allopregnanolone in mice lacking progesterone receptor a and B subtypes

Methods and Findings in Experimental and Clinical Pharmacology, 29(10), 659–664.

Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy

Journal of Neuroscience Research, 83(6), 1088–1105.

Physiological role of adrenal deoxycorticosterone-derived neuroactive steroids in stress-sensitive conditions

Neuroscience, 138(3), 911–920.

A high-performance liquid chromatography-tandem mass spectrometry assay of the androgenic neurosteroid 3 alpha-androstanediol (5 alpha-androstane-3 alpha,17 beta-diol) in plasma

Steroids, 70(13), 879–885.

Anesthetic effects of progesterone are undiminished in progesterone receptor knockout mice

Brain Research, 1033(1), 96–101.

Anxiolytic activity of progesterone in progesterone receptor knockout mice

Neuropharmacology, 48(1), 14–24.

Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice

Journal of Pharmacology and Experimental Therapeutics, 310(1), 230–239.

Anticonvulsant activity of the testosterone-derived neurosteroid 3 alpha-androstanediol

NeuroReport, 15(3), 515–518.

Ganaxolone: A prospective overview

Drugs of the Future, 29(3), 227–242.

Pharmacology of catamenial epilepsy

[Review of ]. Methods and Findings in Experimental and Clinical Pharmacology, 26(7), 547–561.

Role of neurosteroids in catamenial epilepsy

Epilepsy Research, 62(03-Feb), 99–118.

Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3 alpha-androstanediol and 17 beta-estradiol

Neuroscience, 129(1), 195–207.

Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?

Trends in Pharmacological Sciences, 24(3), 103–106.

Newer gabaergic agents for pharmacotherapy of infantile spasms

Drugs of Today, 38(10), 657–675.

The clinical potentials of endogenous neurosteroids

Drugs of Today, 38(7), 465–485.